Office management of patients with diastolic heart failure.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 2645460)

Published in CMAJ on March 03, 2009

Authors

Katina Tzanetos1, Derek Leong, Robert C Wu

Author Affiliations

1: Department of Medicine, Division of General Internal Medicine, University Health Network, University of Toronto, Toronto, Ontario.

Articles cited by this

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation (2005) 18.90

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74

Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79

Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med (2006) 10.58

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12

The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med (1997) 5.25

New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation (2002) 4.96

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet (2001) 4.65

Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63

How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J (1998) 4.48

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J (2005) 4.37

The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J (2006) 4.10

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation (2006) 3.40

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19

Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation (2004) 3.15

Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol (2001) 2.93

Epidemiology of diastolic heart failure. Prog Cardiovasc Dis (2005) 2.59

Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med (1997) 2.20

The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart (2008) 1.92

Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol (2000) 1.71

Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med (2004) 1.67

Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol (2001) 1.65

Heart failure with a normal ejection fraction. Heart (2005) 1.41

Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med (2006) 1.36

Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail (2002) 1.31

Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am J Cardiol (1997) 1.19

Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol (2002) 1.18

Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation (1990) 1.14

Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung (2004) 1.12

Exercise self-efficacy in older women with diastolic heart failure: results of a walking program and education intervention. J Gerontol Nurs (2006) 1.08

Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients. Am J Manag Care (2005) 1.07

Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis (2005) 1.02

The treatment of heart failure with preserved ejection fraction ("diastolic heart failure"). Heart Fail Rev (2006) 0.96

Therapy for diastolic heart failure. Prog Cardiovasc Dis (2005) 0.92

The effect of quinapril on functional status of elderly patients with diastolic heart failure. Cardiovasc Drugs Ther (2003) 0.89

Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol (1993) 0.89

Diastolic heart failure and left ventricular diastolic dysfunction: what we know, and what we don't know! Int J Cardiol (2006) 0.87

The epidemiological enigma of heart failure with preserved systolic function. Eur J Heart Fail (2004) 0.86

Physical function and quality of life in older women with diastolic heart failure: effects of a progressive walking program on sleep patterns. Prog Cardiovasc Nurs (2007) 0.85

Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure. Int J Clin Pract (2002) 0.81

Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction. Am J Cardiol (2004) 0.81

Clinical trials in diastolic heart failure. Prog Cardiovasc Dis (2005) 0.78

Effects of lisinopril on congestive heart failure in normotensive patients with diastolic dysfunction but intact systolic function. Eur J Clin Pharmacol (1995) 0.76

Management of diastolic heart failure--a practical review of pathophysiology and treatment trial data. Int J Clin Pract (2005) 0.76

Articles by these authors

Evaluation of the accuracy of smartphone medical calculation apps. J Med Internet Res (2014) 1.39

Medical students and personal smartphones in the clinical environment: the impact on confidentiality of personal health information and professionalism. J Med Internet Res (2014) 1.07

The use of smartphones in general and internal medicine units: a boon or a bane to the promotion of interprofessional collaboration? J Interprof Care (2012) 1.04

Implementation of a continuous admission model reduces the length of stay of patients on an internal medicine clinical teaching unit. J Hosp Med (2011) 1.02

It's not about pager replacement: an in-depth look at the interprofessional nature of communication in healthcare. J Hosp Med (2013) 0.92

How much do operational processes affect hospital inpatient discharge rates? J Public Health (Oxf) (2009) 0.82

String-like micellar nanoparticles formed by complexation of PEG-b-PPA and plasmid DNA and their transfection efficiency. Pharm Res (2011) 0.81

Dynamic article: combined endoscopic-laparoscopic surgery for complex colonic polyps: postoperative outcomes and video demonstration of 3 key operative techniques. Dis Colon Rectum (2015) 0.81

Probing in vivo trafficking of polymer/DNA micellar nanoparticles using SPECT/CT imaging. Mol Ther (2011) 0.80

An evidence-based case for the value of social workers in efficient hospital discharge. Health Care Manag (Frederick) (2011) 0.79

Smoothing inpatient discharges decreases emergency department congestion: a system dynamics simulation model. Emerg Med J (2010) 0.78

Real-time operational feedback: daily discharge rate as a novel hospital efficiency metric. Qual Saf Health Care (2010) 0.77

Analysis of Smartphone Interruptions on Academic General Internal Medicine Wards. Frequent Interruptions may cause a 'Crisis Mode' Work Climate. Appl Clin Inform (2017) 0.75